“will now pursue marketing efforts in Europe and, in parallel, begin plans for the filing of a 510k application with the United States FDA for marketing clearance in the United States...”
They’ve (Hema) previously mentioned in their filings they would be filing an application for 510k clearance. Overall, a sign of real progress.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links